Clinical Trials Logo

Clinical Trial Details — Status: Active, not recruiting

Administrative data

NCT number NCT06140628
Other study ID # W23021025
Secondary ID
Status Active, not recruiting
Phase N/A
First received
Last updated
Start date September 24, 2023
Est. completion date April 30, 2024

Study information

Verified date December 2023
Source Botanee Group Co., Ltd.
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This clinical trial aims to learn about the efficacy of MLYAAT-1002® (a proprietary anti-aging complex, MLYAAT is short for "multi-layer anti-ageing technology" ) in female subjects who have newly received the rejuvenation treatment by comparing visual clinical scores, skin attributes measurement and image analysis.


Description:

The main expectation it aims to answer are: - After the 4-week continuous use of the test skin product with MLYAAT-1002®, the skin aging problem is significantly improved compared with it of controlled product. - After the single use of the test skin product with MLYAAT-1002®, the instant skin irritation after the Fotona4D Pro® treatment ( a nonablative fractional laser treatment for facial skin rejuvenation) is significantly lower compared with it of controlled product. - After the 4-week continuous use of the test skin product with MLYAAT-1002®, the skin TEWL (transepidermal water loss) is significantly recovered from the Fotona4D Pro® treatment compared with it of controlled product. And the skin TEWL after the 4-week continuous use of test product is improved or not significantly worse than it before the Fotona4D Pro® treatment. - After the 4-week continuous use of the test skin product with MLYAAT-1002®, no skin irritation symptom is worsen compared to it after the Fotona4D Pro® treatment.


Recruitment information / eligibility

Status Active, not recruiting
Enrollment 35
Est. completion date April 30, 2024
Est. primary completion date November 30, 2023
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Female
Age group 30 Years to 50 Years
Eligibility Inclusion Criteria: - females aged 30-50 - no history of cosmetic allergies - according to SKIN AGING ATLAS 2(Asian Type), the scores of under-eye wrinkles, pore appearance, forehead wrinkles are all > 2 - non-sensitive skin - acceptable for split-face use of products for 28 days - no using history of antibiotic in the past three months - written informed consent and portrait right consent were obtained from all participants before study entry Exclusion Criteria: - subjects with known allergies or sensitivities to the ingredients in any of the study products - anyone who is pregnant, nursing an infant, or planning a pregnancy during the study - any symptoms of facial flushing, erythema, papules, desquamation, or edema as evaluated by a physician prior to initial screening or Fotona4D Pro treatment - unhealed skin lesions - participated in any other clinical trial within one month - received facial skin treatments including but not limited to lasers, chemical peels, dermal fillers within one year - taken/injected anti-allergy medication in the past one month - other medical reasons that could affect the test results - participants in other clinical trials at the same time

Study Design


Related Conditions & MeSH terms


Intervention

Combination Product:
Fotona4D Pro® treatment followed by daily use of formulations containing MLYAAT-1002®
Each subject will receive a single treatment of the Fotona4D Pro® , followed by the first application of the active comparator on the randomly assigned side of split-face (the treatment side) on the same day, and sequently, will apply the active comparator to this side twice a day for 28 days.
Fotona4D Pro® treatment followed by daily use of formulations without MLYAAT-1002®
Each subject will receive a single treatment of the Fotona4D Pro® , followed by the first application of the placebo comparator on the randomly assigned side of split-face (the control side) on the same day, and sequently, will apply the placebo comparator to this side twice a day for 28 dayd.

Locations

Country Name City State
China Shanghai China-norm Quality Technical Service Co., Ltd. Shanghai Shanghai

Sponsors (1)

Lead Sponsor Collaborator
Botanee Group Co., Ltd.

Country where clinical trial is conducted

China, 

Outcome

Type Measure Description Time frame Safety issue
Primary changes in individual typology angle (ITA°) of facial skin capturing facial images by VISIA-7 (CANFIELD, America) and calculating the ITA Day 0, Day 3, Day 7, Day 14, Day 28
Primary changes in elasticity of facial skin (R2) measuring gross elasticity (R2) by Cutometer® MPA580 (Courage&Khazaka, Germany) Day 0, Day 3, Day 7, Day 14, Day 28
Primary changes in elasticity of facial skin (F4) measuring firmness (F4) by Cutometer® MPA580 (Courage&Khazaka, Germany) Day 0, Day 3, Day 7, Day 14, Day 28
Primary changes in facial skin topography (SEsm) evaluating skin smoothness (SEsm) using VisioScan VC20(Courage&Khazaka,Germany) Day 0, Day 3, Day 7, Day 14, Day 28
Primary changes in facial skin topography (SEw) evaluating wrinkles (SEw) using VisioScan VC20(Courage&Khazaka,Germany) Day 0, Day 3, Day 7, Day 14, Day 28
Primary changes in fine line depth of facial skin evaluating peri orbital fine lines by Primos(CANFIELD, America) Day 0, Day 3, Day 7, Day 14, Day 28
Primary changes in wrinkle depth of facial skin evaluating crow's feet wrinkles by Primos(CANFIELD, America) Day 0, Day 3, Day 7, Day 14, Day 28
Primary changes in skin thickness of facial skin measuring skin thickness in µm by Ultrascan UC22(Courage&Khazaka,Germany) Day 0, Day 3, Day 7, Day 14, Day 28
Primary changes in skin density of facial skin measuring skin density (ultrasound density in % ) by Ultrascan UC22(Courage&Khazaka,Germany) Day 0, Day 3, Day 7, Day 14, Day 28
Secondary changes in transepidermal water loss (TEWL,in g/m2/h) of facial skin measuring the loss of water that passes from inside a body through the epidermis to the surrounding atmosphere by Tewameter® MPA580 (Courage&Khazaka,Germany) Day 0, Day 3, Day 7, Day 14, Day 28
See also
  Status Clinical Trial Phase
Completed NCT05098912 - Comparing Polydioxanone Thread Embedding Acupuncture and Manual Acupuncture for Nasolabial Fold Reduction N/A
Completed NCT05271136 - A Clinical Study to Evaluate the Efficacy of an Anti-Aging Serum N/A
Completed NCT05096247 - Post Market Study To Collect Efficacy Data For The Treatment Of Wrinkles With A Radiofrequency Device N/A
Completed NCT05097157 - Study To Assess A Radiofrequency Microneedling Device For Dermatologic Conditions N/A
Completed NCT04128046 - The Effect of Platelet-rich Fibrin Matrix on Skin Rejuvenation N/A
Active, not recruiting NCT04727099 - Clinical Evaluation to Demonstrate the Safety and Performance of the Candela PicoWay System™ N/A
Not yet recruiting NCT05524779 - BTL-785F Device for Non-invasive Reduction of Wrinkles and Overall Facial Improvement N/A
Completed NCT05514782 - A Clinical Study to Evaluate the Long-Term Efficacy and Tolerability of a Daily Anti-Aging Daily Serum N/A
Completed NCT06123572 - A Clinical Study to Assess the Safety and Effectiveness of Anti-Ageing and Skin Brightening Gel N/A
Completed NCT04911374 - An Open-Label Clinical Study to Evaluate the Efficacy of a Face Cream and Eye Cream N/A
Recruiting NCT04989361 - Soluble Hyaluronic Acid Microneedle VS. Non-ablative Fractional Laser on Infraorbital Wrinkles. N/A
Recruiting NCT04540900 - A Phase I Study of KB301, a Replication-Incompetent, Non-Integrating Vector Expressing Human Type III Collagen (COL3) for the Treatment of Superficial Skin Depressions Phase 1
Recruiting NCT06074276 - The Effects of Almond on Facial Skin Collagen and Wrinkles N/A
Recruiting NCT06202274 - Clinical Study to Evaluate the Safety and Efficacy of Candela Technology N/A
Completed NCT06366503 - Evaluating Procedure Pairing of a Post-Procedure Cream Versus a Comparator in Patients Treated With Fractional Ablative CO2 Laser for Facial Rejuvenation N/A
Active, not recruiting NCT06219278 - A Retrospective Review Evaluating the Matrix Pro Applicator for Treatment of Wrinkles N/A
Active, not recruiting NCT06192550 - Functional Usability and Feasibility Testing of the Profound Matrix™ System N/A
Completed NCT04650620 - Study to Evaluate the Performance and Safety of the Medical Device Plenhyage® N/A
Completed NCT03729700 - The Effect of Almonds on Facial Aesthetics and Modulation of the Microbiome and Lipidome N/A
Completed NCT05102617 - Post Market Usability Evaluation Of The PicoSure Pro Device N/A